drugset / Trial / NCT05807035
Autologous Tumour Vaccine Trial
Phase 1
Recruiting
30 enrolled
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
Phase 1 trial to evaluate the feasibility of preparation, safety, tolerability and response to a personalised autologous tumour vaccine (ATV) formulated with Advax adjuvant when administered to patients with advanced solid cancers either as monotherapy or in combination with other standard of care agents
Timeline
- Start
- 2023-02-10
- Primary completion
- 2026-02-10
- Completion
- 2028-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Radvax | Unknown | — | — |